Patent · US Active

Combination of a pyrroloquinoline compound and a beta-lactam antimicrobial agent, mupirocin or chlorhexidine

US8940723B2 · kind B2 · utility

2Cited by

0References

22Claims

0Family size

Assignee

Helperby Therapeutics Limited · GB

Inventors

Yanmin Hu · London, GB
Anthony Coates · London, GB

Key dates

Filing date	Aug 5, 2011
Grant date	Jan 27, 2015
Priority date	—
Expiry date	Aug 5, 2031

Classification

Technology area (CPC Y)Emerging Cross-Sectional Technologies
CPC primaryY02A50/30
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

This invention relates to the use of 4-methyl-8-phenoxy-1-(2-phenylethyl)-2,3-dihydro-1H-pyrrolo[3,2-c]quinoline or a pharmaceutically acceptable derivative thereof in combination with another antimicrobial agent selected from the group consisting of a beta-lactam antimicrobial agent, mupirocin and chlorhexidine or a pharmaceutically acceptable derivative thereof, for the prevention and/or treatment of microbial infections.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.